{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:44:47Z","timestamp":1790642687607,"version":"4.1.0"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1001\/jamaophthalmol.2018.5398","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T16:06:13Z","timestamp":1542038773000},"page":"139","source":"Crossref","is-referenced-by-count":33,"title":["Association of Macular Visual Field Measurements With Glaucoma Staging Systems"],"prefix":"10.1001","volume":"137","author":[{"given":"Carlos Gustavo","family":"De Moraes","sequence":"first","affiliation":[{"name":"Bernard and Shirlee Brown Glaucoma Research Laboratory, Edward S. Harkness Eye Institute, Columbia University Medical Center, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Psychology, Columbia University, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravivarn","family":"Jarukasetphon","sequence":"additional","affiliation":[{"name":"Einhorn Clinical Research Center, New York Eye and Ear Infirmary of Mount Sinai, New York City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Rajshekhar","sequence":"additional","affiliation":[{"name":"Department of Psychology, Columbia University, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Psychology, Columbia University, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana M.","family":"Blumberg","sequence":"additional","affiliation":[{"name":"Bernard and Shirlee Brown Glaucoma Research Laboratory, Edward S. Harkness Eye Institute, Columbia University Medical Center, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Liebmann","sequence":"additional","affiliation":[{"name":"Bernard and Shirlee Brown Glaucoma Research Laboratory, Edward S. Harkness Eye Institute, Columbia University Medical Center, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ritch","sequence":"additional","affiliation":[{"name":"Einhorn Clinical Research Center, New York Eye and Ear Infirmary of Mount Sinai, New York City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald C.","family":"Hood","sequence":"additional","affiliation":[{"name":"Bernard and Shirlee Brown Glaucoma Research Laboratory, Edward S. Harkness Eye Institute, Columbia University Medical Center, New York City, New York"},{"name":"Department of Psychology, Columbia University, New York City, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9422","key":"eoi180094r1","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","article-title":"Primary open-angle glaucoma.","volume":"363","author":"Weinreb","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"eoi180094r2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ophtha.2006.05.075","article-title":"Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study.","volume":"114","author":"Miglior","year":"2007","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi180094r3","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/archopht.120.6.714","article-title":"The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.","volume":"120","author":"Gordon","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"eoi180094r4","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","article-title":"Predictors of long-term progression in the early manifest glaucoma trial.","volume":"114","author":"Leske","year":"2007","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi180094r5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ophtha.2008.08.051","article-title":"Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors.","volume":"116","author":"Musch","year":"2009","journal-title":"Ophthalmology"},{"issue":"4","key":"eoi180094r6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7, the relationship between control of intraocular pressure and visual field deterioration.","volume":"130","author":"The AGIS Investigators","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"eoi180094r7","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.ophtha.2017.04.021","article-title":"24-2 visual fields miss central defects shown on 10-2 tests in glaucoma suspects, ocular hypertensives, and early glaucoma.","volume":"124","author":"De Moraes","year":"2017","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi180094r8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/tvst.5.2.15","article-title":"The 24-2 visual field test misses central macular damage confirmed by the 10-2 visual field test and optical coherence tomography.","volume":"5","author":"Grillo","year":"2016","journal-title":"Transl Vis Sci Technol"},{"key":"eoi180094r9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ajo.2015.10.007","article-title":"Clinical clues to predict the presence of parafoveal scotoma on Humphrey 10-2 visual field using a Humphrey 24-2 visual field.","volume":"161","author":"Park","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"eoi180094r10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ajo.2016.05.003","article-title":"Prevalence, features, and severity of glaucomatous visual field loss measured with the 10-2 achromatic threshold visual field test.","volume":"168","author":"Sullivan-Mee","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"eoi180094r11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2012.08.003","article-title":"Glaucomatous damage of the macula.","volume":"32","author":"Hood","year":"2013","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"eoi180094r12","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1167\/iovs.10-5803","article-title":"Initial arcuate defects within the central 10 degrees in glaucoma.","volume":"52","author":"Hood","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"eoi180094r14","doi-asserted-by":"publisher","first-page":"5685","DOI":"10.1167\/iovs.09-5067","article-title":"Spatial pattern of glaucomatous visual field loss obtained with regionally condensed stimulus arrangements.","volume":"51","author":"Schiefer","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"eoi180094r15","doi-asserted-by":"publisher","first-page":"e0186793","DOI":"10.1371\/journal.pone.0186793","article-title":"Detection of central visual field defects in early glaucomatous eyes: comparison of Humphrey and Octopus perimetry.","volume":"12","author":"Roberti","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"eoi180094r16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/tvst.4.6.4","article-title":"Central glaucomatous damage of the macula can be overlooked by conventional OCT retinal nerve fiber layer thickness analyses.","volume":"4","author":"Wang","year":"2015","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"eoi180094r17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/tvst.5.6.4","article-title":"A single wide-field OCT protocol can provide compelling information for the diagnosis of early glaucoma.","volume":"5","author":"Hood","year":"2016","journal-title":"Transl Vis Sci Technol"},{"key":"eoi180094r18","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/bjophthalmol-2014-305156","article-title":"On improving the use of OCT imaging for detecting glaucomatous damage.","volume":"98","author":"Hood","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"eoi180094r19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.preteyeres.2016.12.002","article-title":"Improving our understanding, and detection, of glaucomatous damage: an approach based upon optical coherence tomography (OCT).","volume":"57","author":"Hood","year":"2017","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"eoi180094r20","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.ophtha.2017.03.014","article-title":"Temporal relation between macular ganglion cell-inner plexiform layer loss and peripapillary retinal nerve fiber layer loss in glaucoma.","volume":"124","author":"Kim","year":"2017","journal-title":"Ophthalmology"},{"issue":"11","key":"eoi180094r21","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1001\/archopht.1997.01100160617016","article-title":"Visual function and quality of life among patients with glaucoma.","volume":"115","author":"Parrish","year":"1997","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"eoi180094r22","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.ajo.2007.02.022","article-title":"Severity of visual field loss and health-related quality of life.","volume":"143","author":"McKean-Cowdin","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"eoi180094r23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.survophthal.2006.12.008","article-title":"Staging functional damage in glaucoma: review of different classification methods.","volume":"52","author":"Brusini","year":"2007","journal-title":"Surv Ophthalmol"},{"key":"eoi180094r25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1874364100903010059","article-title":"Staging glaucoma patient: why and how?","volume":"3","author":"Susanna","year":"2009","journal-title":"Open Ophthalmol J"},{"issue":"2","key":"eoi180094r26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ajo.2007.09.038","article-title":"A visual field index for calculation of glaucoma rate of progression.","volume":"145","author":"Bengtsson","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"eoi180094r27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/01.ijg.0000195932.48288.97","article-title":"Enhanced glaucoma staging system (GSS 2) for classifying functional damage in glaucoma.","volume":"15","author":"Brusini","year":"2006","journal-title":"J Glaucoma"},{"issue":"7","key":"eoi180094r28","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1001\/jamaophthalmol.2017.1396","article-title":"Association between undetected 10-2 visual field damage and vision-related quality of life in patients with glaucoma.","volume":"135","author":"Blumberg","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"eoi180094r29","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1167\/iovs.17-23713","article-title":"Challenges to the common clinical paradigm for diagnosis of glaucomatous damage with oct and visual fields.","volume":"59","author":"Hood","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"eoi180094r30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/jamaophthalmol.2013.7656","article-title":"Prevalence and nature of early glaucomatous defects in the central 10\u00b0 of the visual field.","volume":"132","author":"Traynis","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"eoi180094r31","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1167\/iovs.05-0135","article-title":"Threshold and variability properties of matrix frequency-doubling technology and standard automated perimetry in glaucoma.","volume":"46","author":"Artes","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"eoi180094r32","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/IJG.0000000000000690","article-title":"Effect of the eye tracking system on the reproducibility of measurements obtained with spectral-domain optical coherence tomography in glaucoma.","volume":"26","author":"Abadia","year":"2017","journal-title":"J Glaucoma"},{"key":"eoi180094r33","first-page":"S0002-9394(18)30392-1","article-title":"Macular damage, as determined by structure-function staging, is associated with worse vision-related quality of life in early glaucoma.","author":"Garg","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"eoi180094r13","first-page":"67","volume-title":"Measurements for Description of Very Early Glaucomatous Field Defects: Perimetry Update","author":"Langerhorst","year":"1997"},{"key":"eoi180094r24","volume-title":"Clinical Decisions in Glaucoma","author":"Hodapp","year":"1993"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaophthalmology\/article-pdf\/137\/2\/139\/17294609\/jamaophthalmology_de_moraes_2018_oi_180094.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T11:58:02Z","timestamp":1550145482000},"score":1,"resource":{"primary":{"URL":"http:\/\/archopht.jamanetwork.com\/article.aspx?doi=10.1001\/jamaophthalmol.2018.5398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.5398","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2,1]]}}}